Amylyx Pharmaceuticals (AMLX) Earnings Date & Reports

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on developing novel therapies for communities with high unmet medical needs... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

AMLX is expected to report earnings to fall 3.05% to -37 cents per share on November 05

Amylyx Pharmaceuticals AMLX Stock Earnings Reports

Q3'26

Est.

$-0.38

Q2'26

Missed

by $0.04

Q1'26

Missed

by $0.04

Q4'25

Beat

by $0.04

Q3'25

Beat

by $0.08

The last earnings report on August 06 showed earnings per share of -38 cents, missing the estimate of -34 cents. With 2.21M shares outstanding, the current market capitalization sits at 4.31B.

View a ticker or compare two or three

AMLX

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days